296 related articles for article (PubMed ID: 22432004)
1. Identification of common biological pathways and drug targets across multiple respiratory viruses based on human host gene expression analysis.
Smith SB; Dampier W; Tozeren A; Brown JR; Magid-Slav M
PLoS One; 2012; 7(3):e33174. PubMed ID: 22432004
[TBL] [Abstract][Full Text] [Related]
2. GBP5 Is an Interferon-Induced Inhibitor of Respiratory Syncytial Virus.
Li Z; Qu X; Liu X; Huan C; Wang H; Zhao Z; Yang X; Hua S; Zhang W
J Virol; 2020 Oct; 94(21):. PubMed ID: 32796072
[TBL] [Abstract][Full Text] [Related]
3. A Meta-Analysis of Multiple Whole Blood Gene Expression Data Unveils a Diagnostic Host-Response Transcript Signature for Respiratory Syncytial Virus.
Barral-Arca R; Gómez-Carballa A; Cebey-López M; Bello X; Martinón-Torres F; Salas A
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32155831
[TBL] [Abstract][Full Text] [Related]
4. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses.
Ohol YM; Wang Z; Kemble G; Duke G
PLoS One; 2015; 10(12):e0144648. PubMed ID: 26659560
[TBL] [Abstract][Full Text] [Related]
5. Drug candidates and model systems in respiratory syncytial virus antiviral drug discovery.
Heylen E; Neyts J; Jochmans D
Biochem Pharmacol; 2017 Mar; 127():1-12. PubMed ID: 27659812
[TBL] [Abstract][Full Text] [Related]
6. Interactome networks between the human respiratory syncytial virus (HRSV), the human metapneumovirus (ΗMPV), and their host: In silico investigation and comparative functional enrichment analysis.
Rouka E; Hatzoglou C; Gourgoulianis KI; Zarogiannis SG
Microb Pathog; 2020 Apr; 141():104000. PubMed ID: 31988005
[TBL] [Abstract][Full Text] [Related]
7. Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus.
Darbeheshti F; Mahdiannasser M; Uhal BD; Ogino S; Gupta S; Rezaei N
Rev Med Virol; 2021 Nov; 31(6):e2234. PubMed ID: 33724604
[TBL] [Abstract][Full Text] [Related]
8. Novel insights into human respiratory syncytial virus-host factor interactions through integrated proteomics and transcriptomics analysis.
Dapat C; Oshitani H
Expert Rev Anti Infect Ther; 2016; 14(3):285-97. PubMed ID: 26760927
[TBL] [Abstract][Full Text] [Related]
9. Molecular Mechanism of Jinchan Oral Liquid in the Treatment of Children with Respiratory Syncytial Virus Pneumonia Based on Network Pharmacology and Molecular Docking Technology.
Shen L; Jiang Y; Lu J; Wang G; Zhang X; He S; Wang C; Li Z
Biomed Res Int; 2021; 2021():6471400. PubMed ID: 34485521
[TBL] [Abstract][Full Text] [Related]
10. Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures.
Pizzorno A; Terrier O; Nicolas de Lamballerie C; Julien T; Padey B; Traversier A; Roche M; Hamelin ME; Rhéaume C; Croze S; Escuret V; Poissy J; Lina B; Legras-Lachuer C; Textoris J; Boivin G; Rosa-Calatrava M
Front Immunol; 2019; 10():60. PubMed ID: 30761132
[TBL] [Abstract][Full Text] [Related]
11. Innate Immune Evasion by Human Respiratory RNA Viruses.
Kikkert M
J Innate Immun; 2020; 12(1):4-20. PubMed ID: 31610541
[TBL] [Abstract][Full Text] [Related]
12. Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR Pathway.
Pattabhi S; Wilkins CR; Dong R; Knoll ML; Posakony J; Kaiser S; Mire CE; Wang ML; Ireton RC; Geisbert TW; Bedard KM; Iadonato SP; Loo YM; Gale M
J Virol; 2015 Dec; 90(5):2372-87. PubMed ID: 26676770
[TBL] [Abstract][Full Text] [Related]
13. Host transcription profiles upon primary respiratory syncytial virus infection.
Janssen R; Pennings J; Hodemaekers H; Buisman A; van Oosten M; de Rond L; Oztürk K; Dormans J; Kimman T; Hoebee B
J Virol; 2007 Jun; 81(11):5958-67. PubMed ID: 17376894
[TBL] [Abstract][Full Text] [Related]
14. Novel Broad-Spectrum Antiviral Inhibitors Targeting Host Factors Essential for Replication of Pathogenic RNA Viruses.
Tampere M; Pettke A; Salata C; Wallner O; Koolmeister T; Cazares-Körner A; Visnes T; Hesselman MC; Kunold E; Wiita E; Kalderén C; Lightowler M; Jemth AS; Lehtiö J; Rosenquist Å; Warpman-Berglund U; Helleday T; Mirazimi A; Jafari R; Puumalainen MR
Viruses; 2020 Dec; 12(12):. PubMed ID: 33322045
[TBL] [Abstract][Full Text] [Related]
15. Host response to respiratory bacterial pathogens as identified by integrated analysis of human gene expression data.
Smith SB; Magid-Slav M; Brown JR
PLoS One; 2013; 8(9):e75607. PubMed ID: 24086587
[TBL] [Abstract][Full Text] [Related]
16. Respiratory syncytial virus infection enhances Pseudomonas aeruginosa biofilm growth through dysregulation of nutritional immunity.
Hendricks MR; Lashua LP; Fischer DK; Flitter BA; Eichinger KM; Durbin JE; Sarkar SN; Coyne CB; Empey KM; Bomberger JM
Proc Natl Acad Sci U S A; 2016 Feb; 113(6):1642-7. PubMed ID: 26729873
[TBL] [Abstract][Full Text] [Related]
17. Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces Respiratory Syncytial Virus Replication
Jorquera PA; Mathew C; Pickens J; Williams C; Luczo JM; Tamir S; Ghildyal R; Tripp RA
J Virol; 2019 Feb; 93(4):. PubMed ID: 30541831
[TBL] [Abstract][Full Text] [Related]
18. Antiviral activity of ginseng extract against respiratory syncytial virus infection.
Lee JS; Ko EJ; Hwang HS; Lee YN; Kwon YM; Kim MC; Kang SM
Int J Mol Med; 2014 Jul; 34(1):183-90. PubMed ID: 24756136
[TBL] [Abstract][Full Text] [Related]
19. Cullin E3 ligases and their rewiring by viral factors.
Mahon C; Krogan NJ; Craik CS; Pick E
Biomolecules; 2014 Oct; 4(4):897-930. PubMed ID: 25314029
[TBL] [Abstract][Full Text] [Related]
20. Wastewater concentrations of human influenza, metapneumovirus, parainfluenza, respiratory syncytial virus, rhinovirus, and seasonal coronavirus nucleic-acids during the COVID-19 pandemic: a surveillance study.
Boehm AB; Hughes B; Duong D; Chan-Herur V; Buchman A; Wolfe MK; White BJ
Lancet Microbe; 2023 May; 4(5):e340-e348. PubMed ID: 36965504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
